|
Volumn 8, Issue 11, 2005, Pages 1413-
|
Taking addiction research into the clinic
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACAMPROSATE;
ACETYLCYSTEINE;
ALCOHOL;
ANTICONVULSIVE AGENT;
BUPRENORPHINE;
CANNABINOID RECEPTOR ANTAGONIST;
COCAINE;
DIAMORPHINE;
DRUGS USED IN THE TREATMENT OF ADDICTION;
METHADONE;
MODAFINIL;
MU OPIATE RECEPTOR AGONIST;
NALTREXONE;
OPIATE ANTAGONIST;
RIMONABANT;
TOPIRAMATE;
VACCINE;
ADDICTION;
ALCOHOLISM;
BINGE EATING DISORDER;
CLINICAL TRIAL;
COCAINE DEPENDENCE;
DISEASE MODEL;
DRUG COST;
DRUG DEPENDENCE;
DRUG DEPENDENCE TREATMENT;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SCREENING;
DRUG SELF ADMINISTRATION;
EDITORIAL;
HEALTH CARE AVAILABILITY;
HEALTH CARE NEED;
HEALTH INSURANCE;
HEROIN DEPENDENCE;
HUMAN;
LEGAL ASPECT;
METHADONE TREATMENT;
NEUROBIOLOGY;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
RELAPSE;
REWARD;
RODENT;
STRESS;
ANIMALS;
CLINICAL TRIALS;
HUMANS;
RESEARCH;
SUBSTANCE-RELATED DISORDERS;
|
EID: 27644525786
PISSN: 10976256
EISSN: None
Source Type: Journal
DOI: 10.1038/nn1105-1413 Document Type: Editorial |
Times cited : (4)
|
References (3)
|